OpenURL Connection Search

Select item for more details and to access through your institution.

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.
Published in:
Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01046-2
By:
- Lund, Thomas;
- Gundesen, Michael Tveden;
- Juul Vangsted, Annette;
- Helleberg, Carsten;
- Haukås, Einar;
- Silkjær, Trine;
- Asmussen, Jon Thor;
- Manuela Teodorescu, Elena;
- Amdi Jensen, Bo;
- Schmidt Slørdahl, Tobias;
- Nahi, Hareth;
- Waage, Anders;
- Abildgaard, Niels;
- Schjesvold, Fredrik
Publication type:
Article
Potential value of pre-planned imaging of bone disease in multiple myeloma.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00880-0
By:
- Gundesen, Michael T.;
- Asmussen, Jon Thor;
- Schjesvold, Fredrik;
- Vangsted, Annette Juul;
- Helleberg, Carsten;
- Haukås, Einar;
- Silkjær, Trine;
- Teodorescu, Elena Manuela;
- Jensen, Bo Amdi;
- Slørdahl, Tobias S.;
- Nahi, Hareth;
- Waage, Anders;
- Abildgaard, Niels;
- Lund, Thomas
Publication type:
Article
2-[18F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32727-w
By:
- Vogsen, Marianne;
- Naghavi-Behzad, Mohammad;
- Harbo, Frederik Graae;
- Jakobsen, Nick Møldrup;
- Gerke, Oke;
- Asmussen, Jon Thor;
- Nissen, Henriette Juel;
- Dahlsgaard-Wallenius, Sara Elisabeth;
- Braad, Poul-Erik;
- Jensen, Jeanette Dupont;
- Ewertz, Marianne;
- Hildebrandt, Malene Grubbe
Publication type:
Article
Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.
Published in:
Molecular Imaging & Biology, 2023, v. 25, n. 4, p. 720, doi. 10.1007/s11307-023-01808-7
By:
- Vestergaard, Sys;
- Gerke, Oke;
- Bay, Mette;
- Madsen, Anders Rørbæk;
- Stilgren, Lis;
- Ejersted, Charlotte;
- Rewers, Kate Isabella;
- Jakobsen, Nick;
- Asmussen, Jon Thor;
- Braad, Poul-Erik;
- Petersen, Henrik;
- Thomassen, Anders;
- Schifter, Søren
Publication type:
Article
Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.
Published in:
Cancers, 2022, v. 14, n. 7, p. 1682, doi. 10.3390/cancers14071682
By:
- Bjørnhart, Birgitte;
- Hansen, Karin Holmskov;
- Asmussen, Jon Thor;
- Jørgensen, Trine Lembrecht;
- Herrstedt, Jørn;
- Schytte, Tine
Publication type:
Article
Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer.
Published in:
Cancers, 2021, v. 13, n. 16, p. 4080, doi. 10.3390/cancers13164080
By:
- Naghavi-Behzad, Mohammad;
- Oltmann, Hjalte Rasmus;
- Alamdari, Tural Asgharzadeh;
- Bülow, Jakob Lykke;
- Ljungstrøm, Lasse;
- Braad, Poul-Erik;
- Asmussen, Jon Thor;
- Vogsen, Marianne;
- Kodahl, Annette Raskov;
- Gerke, Oke;
- Hildebrandt, Malene Grubbe
Publication type:
Article
Multiple Myeloma Associated Bone Disease.
Published in:
Cancers, 2020, v. 12, n. 8, p. 2113, doi. 10.3390/cancers12082113
By:
- Rasch, Stine;
- Lund, Thomas;
- Asmussen, Jon Thor;
- Lerberg Nielsen, Anne;
- Faebo Larsen, Rikke;
- Østerheden Andersen, Mikkel;
- Abildgaard, Niels
Publication type:
Article
Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study.
Published in:
EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00833-3
By:
- Vogsen, Marianne;
- Jensen, Jeanette Dupont;
- Gerke, Oke;
- Jylling, Anne Marie Bak;
- Asmussen, Jon Thor;
- Christensen, Ivar Yannick;
- Braad, Poul-Erik;
- Thye-Rønn, Peter;
- Søe, Katrine Lydolph;
- Ewertz, Marianne;
- Hildebrandt, Malene Grubbe
Publication type:
Article
A randomised trial of [18F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol.
Published in:
BJUI Compass, 2023, v. 4, n. 5, p. 513, doi. 10.1002/bco2.243
By:
- Buch‐Olsen, Karen Middelbo;
- Poulsen, Mads Hvid;
- Hansen, Steinbjørn;
- Vilstrup, Mie Holm;
- Holm, Jorun;
- Hess, Søren;
- Holdgaard, Paw Christian;
- Zieger, Karsten Egbert Arnold;
- Madsen, Søren Sørensen;
- Gerke, Oke;
- Pedersen, Kasper Tholstrup;
- Dam, Johan Hygum;
- Langkjær, Niels;
- Østergaard, Louise Dorner;
- Asmussen, Jon Thor;
- Braad, Poul Erik;
- Nørgaard, Birgitte;
- Eiber, Matthias;
- Hildebrandt, Malene Grubbe
Publication type:
Article
P-146: A prospective study of conventional skeletal survey versus Whole-body CT for osteolytic lesions in Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S115, doi. 10.1016/S2152-2650(21)02273-4
By:
- Gundesen, Michael;
- Asmussen, Jon Thor;
- Haukås, Einar;
- Schubert, Michael;
- Abildgaard, Niels;
- Schjesvold, Fredrik;
- Lund, Thomas
Publication type:
Article
Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.
Published in:
2022
By:
- Naghavi-Behzad, Mohammad;
- Vogsen, Marianne;
- Vester, Rasmus Mølgård;
- Olsen, Maiken Madsen Bjerregaard;
- Oltmann, Hjalte;
- Braad, Poul-Erik;
- Asmussen, Jon Thor;
- Gerke, Oke;
- Vach, Werner;
- Kidholm, Kristian;
- Kodahl, Annette Raskov;
- Weber, Wolfgang;
- Hildebrandt, Malene Grubbe
Publication type:
journal article
Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.
Published in:
Acta Oncologica, 2017, v. 56, n. 6, p. 874, doi. 10.1080/0284186X.2017.1287427
By:
- Christiansen, Rasmus Lübeck;
- Lorenzen, Ebbe Laugaard;
- Bertelsen, Anders Smedegaard;
- Hansen, Christian Rønn;
- Brink, Carsten;
- Eriksen, Jesper Grau;
- Asmussen, Jon Thor;
- Gyldenkerne, Niels;
- Johansen, Jørgen
Publication type:
Article
Increased Bone Volume by Ixazomib in Multiple Myeloma: 3‐Month Results from an Open Label Phase 2 Study.
Published in:
Journal of Bone & Mineral Research, 2023, v. 38, n. 5, p. 639, doi. 10.1002/jbmr.4807
By:
- Diaz‐delCastillo, Marta;
- Gundesen, Michael Tveden;
- Andersen, Christian Walther;
- Nielsen, Anne Lerberg;
- Møller, Hanne Elisabeth Højsgaard;
- Vinholt, Pernille Just;
- Asmussen, Jon Thor;
- Kristensen, Ida Bruun;
- Nyvold, Charlotte Guldborg;
- Abildgaard, Niels;
- Levin Andersen, Thomas;
- Lund, Thomas
Publication type:
Article
Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43446-7
By:
- Naghavi-Behzad, Mohammad;
- Gerke, Oke;
- Kodahl, Annette Raskov;
- Vogsen, Marianne;
- Asmussen, Jon Thor;
- Weber, Wolfgang;
- Hildebrandt, Malene Grubbe;
- Kidholm, Kristian
Publication type:
Article
Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.
Published in:
Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43446-7
By:
- Naghavi-Behzad, Mohammad;
- Gerke, Oke;
- Kodahl, Annette Raskov;
- Vogsen, Marianne;
- Asmussen, Jon Thor;
- Weber, Wolfgang;
- Hildebrandt, Malene Grubbe;
- Kidholm, Kristian
Publication type:
Article

Found: 15

In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease.

Potential value of pre-planned imaging of bone disease in multiple myeloma.

2-[<sup>18</sup>F]FDG-PET/CT is a better predictor of survival than conventional CT: a prospective study of response monitoring in metastatic breast cancer.

Head-to-Head Comparison of Tc-99m-sestamibi SPECT/CT and C-11-L-Methionin PET/CT in Parathyroid Scanning Before Operation for Primary Hyperparathyroidism.

Effect and Tolerability of Immunotherapy in Patients with NSCLC with or without Brain Metastasis.

Clinical Impact of FDG-PET/CT Compared with CE-CT in Response Monitoring of Metastatic Breast Cancer.

Multiple Myeloma Associated Bone Disease.

Benefits and harms of implementing [<sup>18</sup>F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical study.

A randomised trial of [<sup>18</sup>F]PSMA‐1007‐PET/CT versus NaF‐PET/CT for staging primary prostate cancer: A trial protocol.

P-146: A prospective study of conventional skeletal survey versus Whole-body CT for osteolytic lesions in Multiple Myeloma.

Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.

Contouring and dose calculation in head and neck cancer radiotherapy after reduction of metal artifacts in CT images.

Increased Bone Volume by Ixazomib in Multiple Myeloma: 3‐Month Results from an Open Label Phase 2 Study.

Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.

Cost-effectiveness of 2-[<sup>18</sup>F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study.